Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today advises that it will release its financial results for the half-year ended June 30, 2026 on Thursday August 20, 2026. An investor ...
To diagnose low testosterone, doctors look at physical health, evaluate symptoms and order several blood tests for hormonal ...
The 2026 proposal is seemingly shifting the TRT landscape, moving it further from the “use with caution” territory.
3d
FDA’s 2026 testosterone replacement therapy label overhaul seeks to remove age-related restriction
The FDA is rewriting the safety labels on testosterone replacement therapy for the first time in years, and the shift touches ...
Dominick Occhicone, convicted of killing his ex-fiancée's parents in 1986, is on schedule to become the oldest man ever ...
President Joe Biden recently gave an update on his treatment for metastatic prostate cancer. A urologist explains ways to ...
Officials under President Donald Trump want to make it easier for men to get a prescription for testosterone, the latest shift in a decades-long debate over the benefits and risks of replacing the ...
The University College London (UCL) sponsored study evaluates safety, tolerability and radiation dosimetry of an investigational alpha‑emitting PSMA‑targeted radiopharmaceutical therapy, building on ...
FDA and Telix align on advancement into Part 2 of the ProstACT Global Phase 3 study in the United States. FDA agrees with the clinical protocol and proposed statistical framework across three standard ...
Suffering from prostate cancer or benign prostatic hyperplasia (BPH) is not the end of a relationship. Technology and sexologists offer solutions to maintain erections and orgasms, even if ejaculation ...
Dear Dr. Roach: About six years ago, I was diagnosed with prostate cancer. I chose to have a high-intensity focused ultrasound (HIFU), which ultimately wasn't successful. I was told that surgery after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results